Both In Situ and Circulating SLC3A2 Could Be Used as Prognostic Markers for Human Lung Squamous Cell Carcinoma and Lung Adenocarcinoma

SIMPLE SUMMARY: With the continuous progress of diagnosis and treatment technology, the early diagnosis rate and survival rate of lung cancer have improved, but the incidence rate and mortality rate of lung cancer are still very high. Therefore, it has become an urgent problem to analyze the molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dahua, An, Min, Wen, Guimin, Xing, Yanan, Xia, Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658420/
https://www.ncbi.nlm.nih.gov/pubmed/36358610
http://dx.doi.org/10.3390/cancers14215191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658420/
https://www.ncbi.nlm.nih.gov/pubmed/36358610
http://dx.doi.org/10.3390/cancers14215191

Ejemplares similares